Literature DB >> 23616235

Radiation-induced squamous cell carcinoma of the nasopharynx after radiotherapy for nasopharyngeal carcinoma.

Jimmy Yu Wai Chan1, Victor Shing Howe To, Stanley Thian Sze Wong, William Ignace Wei.   

Abstract

BACKGROUND: The purpose of this study was to investigate the treatment outcome of radiation-induced squamous cell carcinoma (SCC) of the nasopharynx after radiotherapy (RT) for nasopharyngeal carcinoma (NPC).
METHODS: We conducted a retrospective review of patients who underwent radiation therapy for NPC, which resulted in radiation-induced SCC of the nasopharynx.
RESULTS: Between 1998 and 2011, 24 patients had radiation-induced SCC of the nasopharynx. The median age of diagnosis was 68.2 years. The majority of patients (66.7%) presented with early-stage NPC initially, and they were treated with RT alone (n = 18) or concurrent chemoradiation (n = 6). The mean latency period for the second malignancy was 10.5 years. All the patients were treated with maxillary-swing nasopharyngectomy. Clear resection margin was achieved in 66.7%, and 75% of those with involved margin received adjuvant RT. The mean follow-up duration was 48.2 months. The overall 5-year actuarial local tumor control was 56% and the overall 5-year disease-free survival was 38%.
CONCLUSION: Radiation-induced SCC of the nasopharynx is rare after RT for NPC. The prognosis remained poor despite aggressive surgery and adjuvant RT.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  nasopharyngeal carcinoma; nasopharynx; radiation-induced malignancy; radiotherapy; squamous cell carcinoma

Mesh:

Year:  2014        PMID: 23616235     DOI: 10.1002/hed.23363

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT.

Authors:  Hsiao-Fei Lee; Jen-Hong Lan; Pei-Ju Chao; Hui-Min Ting; Hui-Chun Chen; Hsuan-Chih Hsu; Tsair-Fwu Lee
Journal:  Cancer Manag Res       Date:  2018-01-18       Impact factor: 3.989

2.  Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.

Authors:  Ying-Peng Peng; Qiao-Dan Liu; Yu-Jing Lin; Shun-Li Peng; Rong Wang; Xi-Wei Xu; Wei Wei; Gui-Hua Zhong; Yu-Ling Zhou; Ya-Qin Zhang; Ye Liu; Si-Yang Wang; Hai-Yu Hong; Zhi-Gang Liu
Journal:  Radiat Oncol       Date:  2021-10-11       Impact factor: 3.481

3.  Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency.

Authors:  Yung-Hsuan Chen; Sheng-Dean Luo; Shao-Chun Wu; Ching-Nung Wu; Tai-Jan Chiu; Yu-Ming Wang; Yao-Hsu Yang; Wei-Chih Chen
Journal:  Cancers (Basel)       Date:  2022-08-04       Impact factor: 6.575

4.  FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.

Authors:  Huajun Xi; Zhengxiang He; Cao Lv
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.